CRL
Charles River Laboratories International, Inc.
October 21, 2026 · market open
- Rarity
- 1.77
- Peak move
- +10.23%
- Float cap
- $15.3B
Still running — rarity and peak move can only rise from here.
Charles River Laboratories International, Inc. is a non-clinical global drug development partner. It provides discovery and safety assessment services, both Good Laboratory Practice and non-GLP, as well as products and services for manufacturing. The company serves pharmaceutical and biotechnology clients, supporting target identification through non-clinical development.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.